Xuantai Pharmaceutical (688247.SH) announced first-half results, net profit of 54.1533 million yuan, an increase of 137.6% over the previous year

Zhitongcaijing · 08/30 12:17

Zhitong Finance App News, Xuantai Pharmaceutical (688247.SH) released its 2024 semi-annual report. The company's revenue was 218 million yuan, up 96.81% year on year; net profit attributable to shareholders of listed companies was 54.1533 million yuan, up 137.60% year on year; net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was 487.934 million yuan, up 167.97% year on year; basic earnings per share were 0.12 yuan/share. It is proposed to distribute a cash dividend of 0.25 yuan (tax included) for every 10 shares to all shareholders.